Insider trade

Alzamend Neuro (ALZN)Director sold ~$7.1K

William B. Horne, Director at Alzamend Neuro, sold ~$7.1K of Alzamend Neuro shares.

~$7.1K
Approx. value · 3,333 sh @ $2.12
Traded
Dec 19, 2025
Filed
Dec 23, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Oct 23, 2025InsiderDirector sold ~$69 of ALZN shares in the open market
  2. Dec 19, 2025 · this disclosureInsiderDirector sold ~$7.1K of ALZN shares in the open market

What came next

  1. Dec 23, 2025InsiderDirector sold ~$3.8K of ALZN shares in the open market
  2. Mar 6, 2026Company filing · Form 8-K · Material agreementSigned an important agreement
  3. Mar 20, 2026Company filing · Form 8-K · Listing noticeReceived a notice from its stock exchange“On March 20, 2026, Alzamend Neuro, Inc., a Delaware corporation (the “ Company ”) received a letter (the “ Letter ”) from the Listing Qualifications staff (the “ Staff ”) of the Nasdaq Stock Market LLC (“ Nasdaq ”) indicating that the Company’s stockholders’ equity as reported in its Quarterly Report on Form 10-Q for the fiscal quarter ended January 31, 2026 (the “ Form 10-Q ”), did not satisfy the continued listing…”
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Alzamend Neuro

For Alzamend Neuro, OQRO holds 3 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ALZN page.

Other recent filings by William B. Horne, Director

The full history of William B. Horne, Director is on the profile page.

How this filing works

Other disclosures at Alzamend Neuro

Everything OQRO holds on this company is on its ALZN page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data